Get startedLog in
    Picture of Faron Pharmaceuticals Oy logo

    FARN — Faron Pharmaceuticals Oy News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Faron Pharmaceuticals Says FDA Grants Orphan Drug Designation

    Picture of Faron Pharmaceuticals Oy logoFaron Pharmaceuticals Oy
    03/03/2025 12:36
    March 3 (Reuters) - Faron Pharmaceuticals Oy FARN.L:

FARON PHARMA. OY  - FDA GRANTS ORPHAN DRUG DESIGNATION

FARON PHARMACEUTICALS OY - FDA GRANTS ORPHAN DRUG DESIGNATION FOR FARON'S BEXMARILIMAB IN MDS

FARON PHARMACEUTICALS OY: ON TRACK TO REPORT FRONTLINE AND HMA-FAILED (R/R) MDS TOP-LINE EFFICACY RESULTS IN APRIL 2025

Source text: ID:nRSC1174Za

Further company coverage: FARN.L

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Faron Pharmaceuticals Oy

    See all news